Dies ist eine HTML Version eines Anhanges der Informationsfreiheitsanfrage 'Meetings'.

From:
 (SANTE)
Sent:
Wednesday 31 March 2021 15:09
To:
SANTE)
Subject:
BTO report: presentation of RRF (health system focus) to of AmCham EU’s healthcare 
committee
Attachments:
2021-03-30 AmCham.pptx; 2021-03-30 AmCham.pptx
Dear 
 
Yesterday I joined the AmCham EU’s healthcare committee (30 March 1.30)PM – 2.30PM) to present the Recovery and 
Resilience Facility. 
The presentation was delivered following AmCham’s request to the Commission.  
Next to 
 (AmCham) the below industry representatives attended. 
I presented the attached PPT 
From the floor I received the following questions: 
 The role of the RRF as regards long‐term care and the digital transformation
o
I reiterated general eligibility criteria
o I explained eHealth was explicitly referred to in the Commission’s RRP guidance
o I referred to various country reports across European Semesters that also touched upon coordination
challenges between healthcare and long‐term care
 The need for certain high‐cost medicines to be considered as “investments” (for national accounting purposes)
o I referred to parallel debates:

Pharmaceutical strategy and novel payment models

Eurostat and accounting rules
 The need to ensure long‐term reform momentum, also in the macro‐economic aftermath of COVID‐19
o I explained that one of the assessment criteria as explained in RRP guidance deals with the sustainability
of investments
o Overall, prior to COVID‐19 health systems were showing showing promising signs of resiliently coping
with demographic ageing( e.g. healthcare expenditures as a share of GDP stabilized)
(there was also a request to comment on the inception impact assessment/roadmap published yesterday on the review 
of the EU pharmaceutical acquis, which I declined) 
1





 
 
 
  
 
European Commission 
Directorate-General for Health and Food Safety 
Unit B1 Performance of national health systems 
 
B-1049 Brussels/Belgium 
+
  @ec.europa.eu 
 
2